NDC 72934-1066

DAPSONE 8.5% / NIACINAMIDE 4%

Dapsone 8.5% / Niacinamide 4%

DAPSONE 8.5% / NIACINAMIDE 4% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Dapsone; Niacinamide.

Product ID72934-1066_8738b667-e55c-5543-e053-2991aa0a5530
NDC72934-1066
Product TypeHuman Prescription Drug
Proprietary NameDAPSONE 8.5% / NIACINAMIDE 4%
Generic NameDapsone 8.5% / Niacinamide 4%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameDAPSONE; NIACINAMIDE
Active Ingredient Strength9 g/100g; g/100g
Pharm ClassesSulfone [EPC],Sulfones [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1066-2

30 g in 1 BOTTLE, PUMP (72934-1066-2)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1066-2 [72934106602]

DAPSONE 8.5% / NIACINAMIDE 4% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
DAPSONE8.5 g/100g

Pharmacological Class

  • Sulfone [EPC]
  • Sulfones [CS]
  • Sulfone [EPC]
  • Sulfones [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.